Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Net Cash Flow (2016 - 2021)

Historic Net Cash Flow for Phio Pharmaceuticals (PHIO) over the last 10 years, with Q4 2021 value amounting to -$2.5 million.

  • Phio Pharmaceuticals' Net Cash Flow rose 579.27% to -$2.5 million in Q4 2021 from the same period last year, while for Dec 2021 it was $9.8 million, marking a year-over-year increase of 3424.08%. This contributed to the annual value of -$3.1 million for FY2024, which is 697.4% up from last year.
  • As of Q4 2021, Phio Pharmaceuticals' Net Cash Flow stood at -$2.5 million, which was up 579.27% from -$2.9 million recorded in Q3 2021.
  • In the past 5 years, Phio Pharmaceuticals' Net Cash Flow ranged from a high of $18.5 million in Q1 2021 and a low of -$3.3 million during Q2 2021
  • Moreover, its 5-year median value for Net Cash Flow was -$2.0 million (2018), whereas its average is $557550.0.
  • Per our database at Business Quant, Phio Pharmaceuticals' Net Cash Flow tumbled by 59527.78% in 2017 and then surged by 73427.79% in 2018.
  • Phio Pharmaceuticals' Net Cash Flow (Quarter) stood at -$1.8 million in 2017, then skyrocketed by 734.28% to $11.6 million in 2018, then crashed by 115.25% to -$1.8 million in 2019, then crashed by 47.83% to -$2.6 million in 2020, then grew by 5.79% to -$2.5 million in 2021.
  • Its Net Cash Flow was -$2.5 million in Q4 2021, compared to -$2.9 million in Q3 2021 and -$3.3 million in Q2 2021.